The Relationship Between Haemodialysis and Haematological Parameter Levels in Patients with End-Stage Renal Failure
Research Article
DOI:
https://doi.org/10.5281/zenodo.11363698Keywords:
End-Stage Renal Disease, Renal Replacement Therapy, Lymphocyte Neutrophil Rate, HemodialysisAbstract
Introduction: To be able to detect proinflammatory response with cytokines such as CRP, IL-1,IL-6 in chronic renal disease patients; it is showed in some recent studies that neutrophil lmyphocyte ratio could be just as useful as other inflammatory markers.
Aim: This study purposes to show possible changes and likelyhood of inflammatory response in patients with end stage renal disesase who either follows renal replacement therapy or conservative therapy without hemodialysis within using neutrophil lmyphocyte ratio as a denovo marker.
Metods: In our study group some of these patients rejected to enter hemodialysis programme. We examined retrospectively the patients who applied during 2013-2018 to nephrology policlinics of an university hospital. It is included a to a total number of 115 patients: 59 patient who rejected RRT, so only get followed with conservative approach; 56 patient who enters hemodialysis programme. The data obtained retrospectively through patient files and and includes: levels of urea, uric acid, creatinine, GFR, MCV, parathormone, protein/creatinin ratio in spot urine test.
Results: Our Study showed no significant difference within these biochemical parameters in these two group. Although when the complete blood counts of these patients are taken into consideration, the MCVwere significantly higher in the group who followed with conservative treatment (p=0.002). When we tried to examine other possible parameters which can interfere with NLR ratio, there were no significant statistical correlation within.
Conclusion: As a final statement, it should be considered that MCV could be used to evaluate the progression of renal disease, taken account of there was significant difference between our two study groups.
References
Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(4): 2089-2095.
Kovesdy CP, Kalantar-Zadeh K. Inflammation in chronic kidney disease. In Sayegh MH (ed), Chronic Kidney Disease, Dialysis and Transplantation. Philadelphia WB Saunders. 2010; 27 (5): 183-197.
Madeleine V, Nosratola DV. Immune Function in Chronic Kidney Disease. Chronic Renal Disease. 2020; 32: 503-19.
Halazun KJ, Marangoni G, Hakeem A, et al. Elevated preoperative recipient neutrophil-lymphocyte ratio is associated with delayed graft function following kidney transplantation. Transplant Proc. 2013; 45: 3254–57.
Okyay GU, Inal S, Onec K, et al. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail. 2013; 35 (6): 29–36.
Massry, Shaul G, and Richard J. Glassock, eds. Textbook of nephrology. 2001; 2: 1765-83.
Stankuviene A, Bumblyte IA, Kuzminskis V, Ziginskiene E, Balciuviene V. Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998-2005. Medicina (Kaunas). 2007; 43: 96-100.
Bello AK., Alrukhaimi M., Ashuntantang GE., et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney International Supplements. 2017; 7: 122–129.
Toprak O, Bozyel EA, Alp B, Kirik A. Discontinuation of Hemodialysis After 8 Years in Favor of Toprak's Kidney Care in a Patient with End-Stage Kidney Disease. Am J Case Rep. 2021;22: 57.
Turkmen K, Guney I, Yerlikaya FH, Tonbul HZ. The relationship between neutrophil-tolymphocyte ratio and inflammation in endstage renal disease patients. Ren Fail. 2012; 34 :1559.
Dmitrieva O, De Lusignan S, Macdougall IC, et al. Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data; BMC Nephrology. 2013; 14: 24.
Toblli JE, Lombrana A, Duarte P, et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. Journal of the American College of Cardiology. 2007;50: 1657-1665.
Silverstein DM. Inflammation in chronic kidney disease: Role in the progression of renal and cardiovascular disease. Pediatr Nephrol. 2009; 24: 1445-1452.
Neff K, Le Roux C. Chronic kidney disease and inflamation. In:Immunonutrition. New York CRC Press. 2014; 167-180.
Binnetoğlu E, Şengül E, Halhallı G, et al. Is neutrophil lymphocyte ratio an ındicator for proteinuria in chronic kidney disease? J Clin Lab Anal. 2014; 28: 487–492.
Iijima R, Ndrepepa G, Mehilli J, et al. Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions. Pooled analysis of four ISAR trials. Thromb Haemost. 2007; 98: 852–857.
Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in endstage renal disease patients. Hemodial Int. 2013;17: 391-396.
Balboul Y, Gurshumov A, Azar A, et al. Biological basis of lymphocyte ratios for survival prediction in hemodialysis patients: a longitudinal study. International Urology and Nephrology. 2020.
Yuan Q, Wang J, Peng Z, et al. Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). J Transl Med. 2019; 17: 86.
Tonyali S, Ceylan C, Yahsi S, et al. Does neutrophil to lymphocyte ratio demonstrate deterioration in renal function? Ren Fail. 2018; 40: 209–212.
Yoshitomi R, Nakayama M, Sakoh T, et al. High neutrophil/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease. Ren Fail. 2019;41: 238-243.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Acta Medica Ruha
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.